rBet-v-1 derivatives (Vienna University)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NamerBet-v-1 derivatives (Vienna University)
Drug Alias NameCFPYCYPSESA (1,5 cyclo)birch pollen immunotherapyBet-v-1 mimotopes
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Genetically engineered subunit vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsRhinitis, Allergic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Clinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Vienna
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Vienna
Active IndicationsN/A
Inactive IndicationsRhinitis, Allergic

Other Information

ATC CodeN/A
Related LinksN/A